Concerned about new COVID-19 variants? The FDA is developing a plan to Adapt
Concerned about new variants of the virus that causes COVID-19, the U.S. Food and Drug Administration announced late Thursday that it is developing guidance to help vaccine, drug and testing manufacturers adapt. Existing vaccines, treatments and tests still work well, emphasized the FDA's acting commissioner Janet Woodcock. But now is the time to get ready for a future when they may not. "We must prepare for all eventualities," she said […]
